PharmaCann and LivWell Enlightened Health have entered into a definitive merger agreement pursuant to which PharmaCann will acquire LivWell Holdings.
“This merger increases PharmaCann’s presence in the second and third-largest cannabis markets in the U.S., and provides a strong foundational team and operational platform for PharmaCann’s further expansion into new states. Together we will implement best practices across all of our operations and build upon LivWell’s brand and in producing low-cost, high-quality products,” said Brett Novey, CEO of PharmaCann.
John Lord, Founder and CEO of LivWell Enlightened Health: “This merger will further the patient and customer experience on an expanding national level.”
Upon completion of the planned merger, PharmaCann and LivWell would operate approximately 60 dispensaries and 11 cultivation and production facilities across eight states. It is anticipated that John Lord will join the PharmaCann Board of Directors following the closing of the transaction.